en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
1/2022
vol. 28
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
List do Redakcji

Jakie metody oznaczania C-peptydu powinnyśmy stosować?

Pim Dekker
1
,
Martine de Vries
1
,
Henk-Jan Aanstoot
1
,
Joost Groen
2

1.
Center for Pediatric and Adult Diabetes Care and Research, Rotterdam, The Netherlands
2.
Department of Clinical Chemistry, IJsselland Ziekenhuis, Capelle aan den IJssel, The Netherlands
Pediatr Endocrinol Diabetes Metab 2022; 28 (1): 101–103
Data publikacji online: 2022/03/03
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Many C-peptide assays are commercially available for research and routine use. However, not all assays yield consistent results, especially in the low concentration ranges. We searched the literature describing C-peptide measurements to assess which assays are mainly used in the diabetes research field and if they are specified. Percentages of publications on C-peptide measurements in type 1 diabetes (T1D), type 2 diabetes (T2D) and other forms of diabetes were 32%, 54% and 14%, respectively. In only 54% of the publications the used assay was specified. Information on detection limit, measurement range and variation was provided in 12%, 2% and 11% of publications, respectively. In 22% of all publications no C-peptides concentrations were mentioned. This may be a problem especially for T1D research, where measuring very low levels of C-peptide is becoming increasingly important and concordance between assays is low.

© 2024 Termedia Sp. z o.o.
Developed by Bentus.